Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.
Researched for: AMPA modulation and cognitive function
Also known as: Draganon, Sarpul
Aniracetam is a fat-soluble racetam studied for AMPA receptor positive allosteric modulation, acetylcholine release enhancement, and mGluR1/5 modulation, metabolized to anisoyl-GABA and related compounds. It belongs to the first structural class of racetams (with piracetam, oxiracetam, and phenylpiracetam) explored as cognitive-enhancement add-ons; like other racetams, its precise mechanism remains only partially characterized and clinical evidence quality is mixed/limited.
Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.
Data source: Racetam-class pharmacology review literature
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
Amounts and schedules are separated by administration route. Evidence badges distinguish labels, human studies, preclinical work, community reports, and evidence gaps.
1500 mg/day in divided doses
Context: double-blind multicenter clinical studies in elderly cognitive-impairment populations
Formulation: Oral-mucosal formulations are not dose-equivalent to injectable or topical formulations.
Route safety: Research-study protocol only; it is not an approved or individualized instruction and should not be extrapolated to another route.
Do not convert an amount between routes. Bioavailability, formulation, sterility, monitoring, and clinical context differ by route. Research-use context only; independently verify every cited source.
Typically sold as 750 mg capsules.
Supplementary research context only. Not medical advice or a treatment recommendation.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.